Abstract
Provisional Recommendations are preliminary drafts of IUPAC recommendations on terminology, nomenclature, and symbols, made widely available to allow interested parties to comment before the recommendations are finalized and published in IUPAC’s journal Pure and Applied Chemistry (PAC). Full text is available online.
Glossary and tutorial of xenobiotic metabolism terms used during small molecule drug discovery and development
This project originated nearly 15 years ago with the intent to produce a glossary of drug metabolism terms having definitions especially applicable for use by practicing medicinal chemists. A first-draft version underwent extensive beta-testing that, fortuitously, engaged international audiences having a wide range of disciplines involved in drug discovery and development. It became clear that inclusion of information to enhance discussions among this mix of participants would be even more valuable. The glossary’s present version retains a chemical structure theme, while expanding tutorial comments directed toward bridging various perspectives that may arise for a given term during interdisciplinary communications. It is intended to be educational for early stage researchers, as well as being a useful resource for investigators at various levels who participate on today’s highly multidisciplinary, collaborative drug discovery teams.
Comments by 31 December 2019.
Corresponding Author: Paul Erhardt <Paul.Erhardt@utoledo.edu>
Terminology of electrochemical methods of analysis
Recommendations are given concerning the terminology of methods used in electroanalytical chemistry. Fundamental terms in electrochemistry are reproduced from previous PAC Recommendations, and new and updated material is added for terms in electroanalytical chemistry, classification of electrode systems, and eletroanalytical techniques.
Comments by 30 November 2019.
Corresponding Author: D. Brynn Hibbert <b.hibbert@unsw.edu.au>
©2019 IUPAC & De Gruyter. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. For more information, please visit: http://creativecommons.org/licenses/by-nc-nd/4.0/
